Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication

Vascular Medicine

Volumn 16, Issue 5, 2011, Pages 346-353

  Mohler III, Emile R ^a   Gainer, John L ^b   Whitten, Kim ^b   Eraso, Luis H ^a   Thanaporn, Porama Koy ^c   Bauer, Timothy ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Diffusion Pharmaceuticals LLC   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

claudication; dose response relationship; drug; peripheral artery disease

Indexed keywords

CAROTENOID; PLACEBO; TRANS SODIUM CROCETINATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; TREADMILL;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; VITAMIN A; WALKING;

EID: 80054750780     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X11422742     Document Type: Article

References (16)

1. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 ; 326: 381-386
2. McDermott MM, Mehta S, Liu K, et al. Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease. J Gen Intern Med. 1999 ; 14: 173-181 (Pubitemid 29161775)
3. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001 ; 286: 1599-1606 (Pubitemid 33010284)
4. Hiatt WR, Nawaz D, Brass EP. Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol. 1987 ; 62: 2383-2387 (Pubitemid 17093454)
5. Brass EP, Hiatt WR, Green S. Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion. Vasc Med. 2004 ; 9: 293-301 (Pubitemid 40202246)
6. Brass EP, Hiatt WR. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med. 2000 ; 5: 55-59 (Pubitemid 30143363)
7. Regensteiner JG, Hargarten ME, Rutherford RB, Hiatt WR. Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology. 1993 ; 44: 1-10 (Pubitemid 23033195)
8. Stennett AK, Dempsey GL, Gainer JL. trans-Sodium crocetinate and diffusion enhancement. J Phys Chem B. 2006 ; 110: 18,078-18,080
9. Gainer JL. Trans-sodium crocetinate for treating hypoxia/ischemia. Expert Opin Investig Drugs. 2008 ; 17: 917-924 (Pubitemid 351864328)
10. Manabe H, Okonkwo DO, Gainer JL, Clarke RH, Lee KS. Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation. J Neurosurg. 2010 ; 113: 802-809
11. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation. 1995 ; 92: 614-621
12. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol. 1990 ; 2: 142-152
13. Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA, McDermott M. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010 ; 15: 181-188
14. Stennett AK, Murray RJ, Roy JW, Gainer JL. Trans-sodium crocetinate and hemorrhagic shock. Shock. 2007 ; 28: 339-344 (Pubitemid 47282026)
15. Bauer TA, Regensteiner JG, Brass EP, Hiatt WR. Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol. 1999 ; 87: 809-816 (Pubitemid 29375020)
16. Bauer TA, Brass EP, Barstow TJ, Hiatt WR. Skeletal muscle StO(2) kinetics are slowed during low work rate calf exercise in peripheral arterial disease. Eur J Appl Physiol. 2007 ; 100: 143-151 (Pubitemid 46681634)